1)Hiromatsu Y, Eguchi H, Tani J et al:Graves' ophthalmopathy:epidemiology and natural history. Inter Med 53:353-360, 2014
2)浅井英男・上田直子・雨宮次生:小児の甲状腺機能亢進症と眼症状.眼臨医報 76:1690-1694,1982
3)Krassas GE:Childhood Graves' Orbitopathy. In Wiersinga WM, Kahaly GJ(eds):Graves' Orbitopathy A Multidisciplinary Approach-Questions and Answers 2nd revised edition:239-247, Karger, Basel, 2010
4)Kozaki A, Inoue R, Komoto N et al:Proptosis in dysthyroid ophthalmopathy:a case series of 10931 Japanese cases. Optom Vis Sci 87:200-204, 2010
5)Goldstein SM, Katowitz WR, Moshang T et al:Pediatric thyroid-associated orbitopathy:the Children's Hospital of Philadelphia experience and literature review. Thyroid 18:997-999, 2008
6)Lim NC, Amrith S, Sundar G:Pediatric thyroid eye disease. The Singapore experience. Orbit 33:96-103, 2014
7)Durairaj VD, Bartley GB, Garrity JA:Clinical features and treatment of Graves' ophthalmopathy in pediatric patients. Ophthalmol Plast Reconstr Surg 22:7-12, 2006
8)Chan W, Wong GW, Fan DS et al:Opthalmopathy in childhood Graves' disease. Br J Ophthalmol 86:740-742, 2002
9)Mourits MP, Prummel MF, Wiersinga WM et al:Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol(Oxf) 47:9-14, 1997
10)森 一越・鈴木 繁・川村 研:ステロイド大量療法を連続3クール施行した甲状腺眼症の1例.日本小児科学会雑誌 115:1768-1772,2011
11)Kubo T, Shimizu J, Furujo M et al:An infant case of Graves' disease with opthalmopathy. Endocr J 52:647-650, 2005
12)Prummel MF, Wiersinga WM:Smoking and risk of Graves' disease. JAMA 269:479-482, 1993
13)Neigel JM, Rootman J, Belkin RI et al:Dysthyroid optic neuropathy:the crowded orbital apex syndrome. Ophthalmology 95:1515-1521, 1988
14)Gogakos Al, Boboridis K, Krassas GE:Pediatric aspects in Graves' orbitopathy. Pediatr Endocrinol Rev Suppl 2:234-244, 2010
15)Rivkees SA, Sklar C, Freemark M:The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 83:3767-3776, 1998
16)井上洋一:バセドウ病の病態と治療.Modern Physician 9:1511-1523,1989